Session

25.03.2021     13:30–15:00

Title:
Workshop 11
Antivirals and resistance II
Type:
Workshop

25.03.2021
13:30–15:00

Title:
Workshop 11
Antivirals and resistance II
Type:
Workshop

13:30–13:45
O 61 Singular ACE2-IgG4-Fc fusion protein efficiently inhibits SARS-CoV-2 entry
Julia Sacherl (München/DE)
Talk time: 12 + 3 min

13:45–14:00
O 62 Cationic amphiphilic drugs inhibit glycoprotein-mediated entry of diverse enveloped viruses
Antonia-Patricia Gunesch (Hannover/DE)
Talk time: 12 + 3 min

14:00–14:15
O 63 Targeting cholesterol metabolism as efficient antiviral strategy against the Hepatitis E virus
Mirco Glitscher (Langen/DE)
Talk time: 12 + 3 min

14:15–14:30
O 64 The molecular tweezer CLR01 inhibits cell-free and cell-to-cell spread of cytomegalovirus by disruption of the viral envelope
Jens von Einem (Ulm/DE)
Talk time: 12 + 3 min

14:30–14:45
O 65 Identification of synergistic anticytomegaloviral drug activities using combinations of clinically relevant pharmaceutical kinase inhibitors (PKIs)
Markus Wild (Erlangen/DE)
Talk time: 12 + 3 min

14:45–15:00
O 66 Resistance phenotype of Varicella Zoster virus polymerase polymorphisms generated by two-step homologous recombination
Ruben Rose (Kiel/DE)
Talk time: 12 + 3 min